Indications
Treatment of diabetes mellitus
Composition
- Active substance
- insulin aspart
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Insulin Aspart Injection
- Active substance
- insulin aspart
- ATC code
- A10AB05
- Therapeutic area
- Diabetes Mellitus
- Marketing authorisation holder
- Masuu Pharma Europe Limited
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/006720